Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome

Lade...
Vorschaubild
Dateien
36_apoh.pdf
36_apoh.pdfGröße: 616.94 KBDownloads: 895
Datum
1999
Autor:innen
Schwarzenbacher, Robert
Zeth, Kornelius
Gries, Anna
Kostner, Gerhard M.
Laggner, Peter
Prassl, Ruth
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
The EMBO Journal. 1999, 22(22), pp. 6228-6239. ISSN 0261-4189. eISSN 1460-2075. Available under: doi: 10.1093/emboj/18.22.6228
Zusammenfassung

The high affinity of human plasma β2-glycoprotein I (β2GPI), also known as apolipoprotein-H (ApoH), for negatively charged phospholipids determines its implication in a variety of physiological pathways, including blood coagulation and the immune response. β2GPI is considered to be a cofactor for the binding of serum autoantibodies from antiphospholipid syndrome (APS) and correlated with thrombosis, lupus erythematosus and recurrent fetal loss.We solved the β2GPI structure from a crystal form with 84% solvent and present a model containing all 326 amino acid residues and four glycans. The structure reveals four complement control protein modules and a distinctly folding fifth C-terminal domain arranged like beads on a string to form an elongated J-shaped molecule. Domain V folds into a central β-spiral of four antiparallel β-sheets with two small helices and an extended C-terminal loop region. It carries a distinct positive charge and the sequence motif CKNKEKKC close to the hydrophobic loop composed of residues LAFW (313 316), resulting in an excellent counterpart for interactions with negatively charged amphiphilic substances. The β2GPI structure reveals potential autoantibody-binding sites and supports mutagenesis studies where Trp316 and CKNKEKKC have been found to be essential for the phospholipid-binding capacity of β2GPI.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
apolipoprotein H (ApoH), complement control protein, β2-glycoprotein I, short consensus repeat, sushi domain
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690SCHWARZENBACHER, Robert, Kornelius ZETH, Kay DIEDERICHS, Anna GRIES, Gerhard M. KOSTNER, Peter LAGGNER, Ruth PRASSL, 1999. Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome. In: The EMBO Journal. 1999, 22(22), pp. 6228-6239. ISSN 0261-4189. eISSN 1460-2075. Available under: doi: 10.1093/emboj/18.22.6228
BibTex
@article{Schwarzenbacher1999Cryst-6723,
  year={1999},
  doi={10.1093/emboj/18.22.6228},
  title={Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome},
  number={22},
  volume={22},
  issn={0261-4189},
  journal={The EMBO Journal},
  pages={6228--6239},
  author={Schwarzenbacher, Robert and Zeth, Kornelius and Diederichs, Kay and Gries, Anna and Kostner, Gerhard M. and Laggner, Peter and Prassl, Ruth}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/6723">
    <dc:contributor>Laggner, Peter</dc:contributor>
    <dc:contributor>Diederichs, Kay</dc:contributor>
    <dc:format>application/pdf</dc:format>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:28:42Z</dcterms:available>
    <dcterms:bibliographicCitation>First publ. in: The EMBO Journal 22 (1999), pp. 6228-6239</dcterms:bibliographicCitation>
    <dc:creator>Zeth, Kornelius</dc:creator>
    <dc:creator>Kostner, Gerhard M.</dc:creator>
    <dc:creator>Schwarzenbacher, Robert</dc:creator>
    <dc:creator>Diederichs, Kay</dc:creator>
    <dc:rights>Attribution-NonCommercial-NoDerivs 2.0 Generic</dc:rights>
    <dcterms:abstract xml:lang="eng">The high affinity of human plasma β2-glycoprotein I (β2GPI), also known as apolipoprotein-H (ApoH), for negatively charged phospholipids determines its implication in a variety of physiological pathways, including blood coagulation and the immune response. β2GPI is considered to be a cofactor for the binding of serum autoantibodies from antiphospholipid syndrome (APS) and correlated with thrombosis, lupus erythematosus and recurrent fetal loss.We solved the β2GPI structure from a crystal form with 84% solvent and present a model containing all 326 amino acid residues and four glycans. The structure reveals four complement control protein modules and a distinctly folding fifth C-terminal domain arranged like beads on a string to form an elongated J-shaped molecule. Domain V folds into a central β-spiral of four antiparallel β-sheets with two small helices and an extended C-terminal loop region. It carries a distinct positive charge and the sequence motif CKNKEKKC close to the hydrophobic loop composed of residues LAFW (313 316), resulting in an excellent counterpart for interactions with negatively charged amphiphilic substances. The β2GPI structure reveals potential autoantibody-binding sites and supports mutagenesis studies where Trp316 and CKNKEKKC have been found to be essential for the phospholipid-binding capacity of β2GPI.</dcterms:abstract>
    <dc:contributor>Kostner, Gerhard M.</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:28:42Z</dc:date>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Gries, Anna</dc:contributor>
    <dc:contributor>Schwarzenbacher, Robert</dc:contributor>
    <dc:contributor>Zeth, Kornelius</dc:contributor>
    <dc:creator>Laggner, Peter</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/6723/1/36_apoh.pdf"/>
    <dcterms:issued>1999</dcterms:issued>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/6723/1/36_apoh.pdf"/>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by-nc-nd/2.0/"/>
    <dc:language>eng</dc:language>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Prassl, Ruth</dc:creator>
    <dc:creator>Gries, Anna</dc:creator>
    <dcterms:title>Crystal structure of human β2-glycoprotein I:implications for phospholipid binding and the antiphospholipid syndrome</dcterms:title>
    <dc:contributor>Prassl, Ruth</dc:contributor>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/6723"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Diese Publikation teilen